The clinical significance of CL measurement is clearly established in the pathomechanism of Barth syndrome (BTHS), a monogenic, ultrarare disorder caused by mutations in the TAZ gene that encodes a mitochondrial transacylase, involved in the remodelling of MLCL into mature CL [17,18]. This evidence concerns the gene TAFAZZIN and Barth syndrome.